Cargando…
Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment
Hepatitis B virus (HBV) is a globally prevalent human DNA virus responsible for more than 250 million cases of chronic liver infection, a condition that can lead to liver inflammation, cirrhosis, and hepatocellular carcinoma. Sodium taurocholate co-transporting polypeptide (NTCP), a transmembrane pr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039015/ https://www.ncbi.nlm.nih.gov/pubmed/35495620 http://dx.doi.org/10.3389/fmolb.2022.879817 |
_version_ | 1784694029511819264 |
---|---|
author | Li, Yan Zhou, Jun Li, Tianliang |
author_facet | Li, Yan Zhou, Jun Li, Tianliang |
author_sort | Li, Yan |
collection | PubMed |
description | Hepatitis B virus (HBV) is a globally prevalent human DNA virus responsible for more than 250 million cases of chronic liver infection, a condition that can lead to liver inflammation, cirrhosis, and hepatocellular carcinoma. Sodium taurocholate co-transporting polypeptide (NTCP), a transmembrane protein highly expressed in human hepatocytes and a mediator of bile acid transport, has been identified as the receptor responsible for the cellular entry of both HBV and its satellite, hepatitis delta virus (HDV). This has led to significant advances in our understanding of the HBV life cycle, especially the early steps of infection. HepG2-NTCP cells and human NTCP-expressing transgenic mice have been employed as the primary cell culture and animal models, respectively, for the study of HBV, and represent valuable approaches for investigating its basic biology and developing treatments for infection. However, the mechanisms involved in the regulation of NTCP transcription, translation, post-translational modification, and transport are still largely elusive. Improvements in our understanding of NTCP biology would likely facilitate the design of new therapeutic drugs for the prevention of the de novo infection of naïve hepatocytes. In this review, we provide critical findings regarding NTCP biology and discuss important questions that remain unanswered. |
format | Online Article Text |
id | pubmed-9039015 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90390152022-04-27 Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment Li, Yan Zhou, Jun Li, Tianliang Front Mol Biosci Molecular Biosciences Hepatitis B virus (HBV) is a globally prevalent human DNA virus responsible for more than 250 million cases of chronic liver infection, a condition that can lead to liver inflammation, cirrhosis, and hepatocellular carcinoma. Sodium taurocholate co-transporting polypeptide (NTCP), a transmembrane protein highly expressed in human hepatocytes and a mediator of bile acid transport, has been identified as the receptor responsible for the cellular entry of both HBV and its satellite, hepatitis delta virus (HDV). This has led to significant advances in our understanding of the HBV life cycle, especially the early steps of infection. HepG2-NTCP cells and human NTCP-expressing transgenic mice have been employed as the primary cell culture and animal models, respectively, for the study of HBV, and represent valuable approaches for investigating its basic biology and developing treatments for infection. However, the mechanisms involved in the regulation of NTCP transcription, translation, post-translational modification, and transport are still largely elusive. Improvements in our understanding of NTCP biology would likely facilitate the design of new therapeutic drugs for the prevention of the de novo infection of naïve hepatocytes. In this review, we provide critical findings regarding NTCP biology and discuss important questions that remain unanswered. Frontiers Media S.A. 2022-04-12 /pmc/articles/PMC9039015/ /pubmed/35495620 http://dx.doi.org/10.3389/fmolb.2022.879817 Text en Copyright © 2022 Li, Zhou and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Molecular Biosciences Li, Yan Zhou, Jun Li, Tianliang Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment |
title | Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment |
title_full | Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment |
title_fullStr | Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment |
title_full_unstemmed | Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment |
title_short | Regulation of the HBV Entry Receptor NTCP and its Potential in Hepatitis B Treatment |
title_sort | regulation of the hbv entry receptor ntcp and its potential in hepatitis b treatment |
topic | Molecular Biosciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039015/ https://www.ncbi.nlm.nih.gov/pubmed/35495620 http://dx.doi.org/10.3389/fmolb.2022.879817 |
work_keys_str_mv | AT liyan regulationofthehbventryreceptorntcpanditspotentialinhepatitisbtreatment AT zhoujun regulationofthehbventryreceptorntcpanditspotentialinhepatitisbtreatment AT litianliang regulationofthehbventryreceptorntcpanditspotentialinhepatitisbtreatment |